tenofovir has been researched along with Sensitivity and Specificity in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (41.46) | 29.6817 |
| 2010's | 22 (53.66) | 24.3611 |
| 2020's | 2 (4.88) | 2.80 |
| Authors | Studies |
|---|---|
| Baeten, JM; Defechereux, P; Deutsch, M; Gandhi, M; Glidden, DV; Grant, RM; Mugo, NR; Ngure, K; Okochi, H; Rodrigues, WC; Spinelli, MA; Stalter, R; Vincent, M; Wang, G | 1 |
| Bernasconi, E; Calmy, A; Cavassini, M; Furrer, H; Günthard, HF; Ledergerber, B; Mugglin, C; Rauch, A; Schmid, P; Stöckle, M; Surial, B; Tarr, PE; Wandeler, G | 1 |
| Amara, A; Diliiy Penchala, S; Else, L; Khoo, S; Lamorde, M; Olagunju, A; Waitt, C | 1 |
| Cathcart, AL; Delaney, WE; Kitrinos, KM; Liu, Y | 1 |
| Manosuthi, W; Pinthong, D; Puangpetch, A; Sukasem, C; Tomongkon, S; Wiriyakosol, N | 1 |
| Glaab, WE; Gu, YZ; Pasello Dos Santos, FR; Peiffer, RL; Sistare, FD; Tournade, H; Troth, SP; Vlasakova, K | 1 |
| Aung, WS; Bakshi, RP; Breakey, J; Fuchs, EJ; Hendrix, CW; Johnson, JE; Marzinke, MA; Weld, E | 1 |
| Beijnen, JH; Huitema, AD; Kromdijk, W; Mulder, JW; Pereira, SA; Rosing, H | 1 |
| Gatanaga, H; Kikuchi, Y; Komatsu, H; Nishijima, T; Oka, S; Shimbo, T; Takano, M; Tanuma, J; Teruya, K; Tsukada, K | 1 |
| Broderick, E; Hotta, MT; Wyatt, CM | 1 |
| Baltussen, R; Boucher, CA; Nichols, BE; Nouwen, JL; Sloot, PM; Thuma, PE; van de Vijver, DA; van de Wijgert, J; van Dijk, JH | 1 |
| B, PB; Kilaru, NB; S, KS; V, PK; Valluru, RK | 1 |
| Boyd, A; Delaugerre, C; Girard, PM; Gozlan, J; Lacombe, K; Maylin, S; Simon, F | 1 |
| Amancha, PK; Ansari, AA; Blanchard, EL; Byrareddy, SN; Connor-Stroud, F; Gumber, S; Hong, JJ; Hoxie, JA; Hunter, E; Rogers, KA; Santangelo, PJ; Schuster, DM; Strait, K; Vidakovic, B; Villinger, F; Zurla, C | 1 |
| Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Girard, PM; Lacombefor, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F | 1 |
| Grafelman, D; Ohnmacht, CM; Podany, AT; Sheldon, C | 1 |
| Anekvorapong, R; Cherdtrakulkiat, T; Chiamwongpaet, S; Choopanya, K; Curlin, ME; Gvetadze, RJ; Kittimunkong, S; Leelawiwat, W; Leethochawalit, M; Martin, M; McNicholl, JM; Mock, PA; Paxton, LA; Sangkum, U; Suntharasamai, P; Tararut, P; Vanichseni, S | 1 |
| Chen, L; Ding, Y; Wang, D; Xiao, Q; Yang, J; Yang, W | 1 |
| Chemin, I; Diop, M; Ghosh, S; Guillot, C; Jeng, A; Kane, CT; Lemoine, M; Mboup, S; Mendy, M; Ndow, G; Njie, R; Sow, A; Thursz, M; Toure, S; Zoulim, F | 1 |
| Ray, AS; Rhodes, GR; Wright, MR | 1 |
| Baietto, L; Bonora, S; D'Avolio, A; Di Perri, G; Gonzalez de Requena, D; Sciandra, M; Siccardi, M | 1 |
| Gomes, NA; Joshi, SS; Parekh, SA; Pudage, A; Vaidya, VV | 1 |
| Freedberg, KA; Losina, E; Sax, PE; Schackman, BR; Scott, CA; Walensky, RP | 1 |
| Chatelut, E; Jaafar, A; Malard, L; Massip, P; Séronie-Vivien, S; Tack, I | 1 |
| Bushman, L; Delahunty, T; Fletcher, CV; Robbins, B | 1 |
| Holý, A; Kasicka, V; Sázelová, P; Solínová, V | 1 |
| Chetty, K; Connolly, JO; Edwards, SG; Hall, AM; Lapsley, M; O'Farrell, S; Unwin, RJ; Williams, IG | 1 |
| Goswami, S; Pande, UC; Sanyal, M; Shrivastav, PS; Singhal, P; Yadav, M | 1 |
| Gruters, RA; Luider, TM; Meesters, RJ; Scheuer, RD; van der Ende, ME; van Kampen, JJ | 1 |
| Anderson, PL; Bushman, LR; Kiser, JJ; Klein, B; Ray, ML; Rower, JE; Zheng, JH | 1 |
| Burugula, L; Inamadugu, JK; J V L N, SR; Matta, MK; Pilli, NR | 1 |
| Dhaneshwar, SR; Havele, S | 1 |
| Beijnen, JH; Crommentuyn, KM; Schellens, JH; Sparidans, RW | 1 |
| Aymard, G; Fernandez, C; Lechat, P; Sentenac, S; Thuillier, A | 1 |
| Thompson, M | 1 |
| Crutchley, RD; Kashuba, AD; Rezk, NL | 1 |
| Bushman, L; Delahunty, T; Fletcher, CV | 1 |
| Anderson, PL; Bushman, L; Delahunty, T; Fletcher, CV; King, T; Kiser, J; Ray, M | 1 |
| Delwart, E; Heneine, W; Johnson, JA; Rompay, KK | 1 |
| El Barkil, M; Gagnieu, MC; Guitton, J | 1 |
| Acosta, EP; Bennetto-Hood, C; Long, MC | 1 |
4 trial(s) available for tenofovir and Sensitivity and Specificity
| Article | Year |
|---|---|
A LC/MS/MS method for determination of tenofovir in human plasma and its application to toxicity monitoring.
Topics: Anti-HIV Agents; Chromatography, Liquid; Drug Monitoring; HIV Infections; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir | 2018 |
Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand.
Topics: Adult; Anti-HIV Agents; Female; HIV Antibodies; HIV Infections; HIV-1; HIV-2; Humans; Immunoenzyme Techniques; Male; Mass Screening; Middle Aged; Pre-Exposure Prophylaxis; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Tenofovir; Thailand; Young Adult | 2015 |
Simultaneous determination of pradefovir, PMEA and tenofovir in HBV patient serum using liquid chromatography-tandem mass spectrometry and application to phase 2 clinical trial.
Topics: Adenine; Adult; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Linear Models; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prodrugs; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir | 2016 |
Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
Topics: Adenine; Adult; Anti-Retroviral Agents; Chromatography, Liquid; Cross-Over Studies; Deoxycytidine; Drug Stability; Emtricitabine; Humans; India; Lamivudine; Least-Squares Analysis; Male; Middle Aged; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir; Therapeutic Equivalency | 2010 |
37 other study(ies) available for tenofovir and Sensitivity and Specificity
| Article | Year |
|---|---|
Brief Report: High Accuracy of a Real-Time Urine Antibody-Based Tenofovir Point-of-Care Test Compared With Laboratory-Based ELISA in Diverse Populations.
Topics: Adult; Anti-HIV Agents; Antibodies; Drug Combinations; Drug Monitoring; Emtricitabine; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; Humans; Kenya; Laboratories; Male; Patient Compliance; Point-of-Care Testing; Sensitivity and Specificity; Tenofovir; Uganda | 2020 |
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study.
Topics: Adult; Alanine; Anti-HIV Agents; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; HIV Infections; Humans; Lipids; Male; Middle Aged; Obesity; Sensitivity and Specificity; Tenofovir; Triglycerides; Weight Gain | 2021 |
Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Chromatography, Liquid; Cohort Studies; Dried Blood Spot Testing; Emtricitabine; Female; Humans; Infant; Lamivudine; Linear Models; Milk, Human; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir; Young Adult | 2017 |
Development of a digital droplet PCR assay to measure HBV DNA in patients receiving long-term TDF treatment.
Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Limit of Detection; Polymerase Chain Reaction; Sensitivity and Specificity; Seroconversion; Tenofovir; Viral Load; Virus Replication | 2017 |
Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-induced Renal Tubular Injury in Tenofovir-treated Cynomolgus Monkeys and Beagle Dogs.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Biomarkers; Dogs; Female; Injections, Intravenous; Kidney Tubules; Macaca fascicularis; Male; Sensitivity and Specificity; Species Specificity; Tenofovir | 2018 |
Fecal Coliform Bacterial Detection to Assess Enema Adherence in HIV Prevention Clinical Studies.
Topics: Administration, Rectal; Adult; Anti-HIV Agents; Enema; Enterobacteriaceae; Feces; HIV Infections; Humans; Male; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Sensitivity and Specificity; Sexual Behavior; Tenofovir | 2019 |
Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry.
Topics: Adenine; Antiviral Agents; Chromatography, Liquid; Deoxyribonucleosides; Drug Stability; Humans; Linear Models; Organophosphonates; Reproducibility of Results; Ribavirin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir | 2013 |
Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: a diagnostic accuracy study.
Topics: Adenine; Adult; Alpha-Globulins; Anti-Retroviral Agents; beta 2-Microglobulin; Biomarkers; Chi-Square Distribution; Female; HIV Infections; HIV-1; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Sensitivity and Specificity; Tenofovir | 2013 |
Urine processing impacts uric acid level in HIV-infected adults: implications for diagnosing tenofovir-associated proximal tubulopathy.
Topics: Adenine; Adult; AIDS-Associated Nephropathy; Anti-HIV Agents; HIV Infections; Humans; Organophosphonates; Sensitivity and Specificity; Specimen Handling; Tenofovir; Time Factors; Uric Acid | 2013 |
Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.
Topics: Adenine; Anti-HIV Agents; Cost-Benefit Analysis; Deoxycytidine; Emtricitabine; HIV Infections; HIV-1; Humans; Models, Biological; Organophosphonates; Prevalence; Primary Prevention; Rural Population; Sensitivity and Specificity; Sexual Behavior; Tenofovir; Zambia | 2013 |
High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma.
Topics: Adenine; Chromatography, High Pressure Liquid; Humans; Lamivudine; Linear Models; Male; Nevirapine; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir | 2013 |
Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.
Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Prospective Studies; Sensitivity and Specificity; Tenofovir; Viral Load | 2015 |
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.
Topics: Adenine; Animals; Anti-Retroviral Agents; Copper Radioisotopes; Deoxycytidine; Emtricitabine; Immunohistochemistry; Male; Membrane Glycoproteins; Naphthyridines; Organophosphonates; Positron-Emission Tomography; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Simian Immunodeficiency Virus; Tenofovir; Viral Envelope Proteins; Viremia; Virus Replication; Whole Body Imaging | 2015 |
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Topics: Africa; Antiviral Agents; Biomarkers; Cohort Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tenofovir; Time Factors | 2016 |
Assay development for determination of tenofovir in human plasma by solid phase analytical derivatization and LC-MS/MS.
Topics: Antiviral Agents; Chromatography, Liquid; Drug Stability; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir | 2015 |
Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.
Topics: Antiviral Agents; Benzothiazoles; Costs and Cost Analysis; Diamines; DNA Primers; DNA, Viral; Drug Monitoring; Follow-Up Studies; Gambia; Hepatitis B virus; Hepatitis B, Chronic; Humans; Organic Chemicals; Quinolines; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Senegal; Sensitivity and Specificity; Staining and Labeling; Tenofovir; Time Factors; Viral Load | 2016 |
Lack of evidence for an effect of lopinavir/ritonavir on tenofovir renal clearance.
Topics: Adenine; Creatinine; Drug Interactions; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Tubules; Lopinavir; Male; Organophosphonates; Pyrimidinones; Ritonavir; Sensitivity and Specificity; Tenofovir | 2008 |
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.
Topics: Adenine; Anti-HIV Agents; Calibration; Chromatography, Liquid; Deoxycytidine; Emtricitabine; HIV Infections; Humans; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tenofovir | 2008 |
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study.
Topics: Adenine; Calibration; Chromatography, Liquid; Deoxycytidine; Drug Combinations; Drug Stability; Emtricitabine; Humans; Organophosphonates; Practice Guidelines as Topic; Quality Control; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry; Tenofovir; Therapeutic Equivalency; Time Factors | 2008 |
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cost-Benefit Analysis; Dideoxynucleosides; Drug Costs; Drug Hypersensitivity; Female; Genetic Testing; Health Care Costs; HIV Infections; HLA-B Antigens; Humans; Male; Middle Aged; Models, Biological; Organophosphonates; Pharmacogenetics; Quality-Adjusted Life Years; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tenofovir; Treatment Outcome | 2008 |
Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
Topics: Adenine; Anti-HIV Agents; Biomarkers; Creatinine; Cystatin C; Fanconi Syndrome; HIV Infections; Humans; Hypophosphatemia; Organophosphonates; Retrospective Studies; Sensitivity and Specificity; Tenofovir | 2009 |
The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.
Topics: Adenine; Anti-HIV Agents; Chromatography, High Pressure Liquid; Deoxycytidine; Drug Stability; Emtricitabine; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir | 2009 |
Chiral analysis of anti-acquired immunodeficiency syndrome drug, 9-(R)-[2-(phosphonomethoxy)propyl]adenine (tenofovir), and related antiviral acyclic nucleoside phosphonates by CE using beta-CD as chiral selector.
Topics: Adenine; Anti-HIV Agents; beta-Cyclodextrins; Cidofovir; Cytosine; Electrolytes; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Linear Models; Organophosphonates; Purines; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Tenofovir | 2009 |
Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
Topics: Acetylglucosaminidase; Adenine; Adult; Aged; Albuminuria; Anti-Retroviral Agents; Creatinine; Cross-Sectional Studies; Disease Progression; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Tubules, Proximal; Male; Middle Aged; Organophosphonates; Phosphates; Proteinuria; Retinol-Binding Proteins; Risk Factors; Sensitivity and Specificity; Tenofovir | 2009 |
Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry.
Topics: Adenine; Adult; Anti-HIV Agents; HIV Infections; Humans; Isotope Labeling; Linear Models; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry; Tenofovir; Triglycerides | 2011 |
Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.
Topics: Adenine; Anion Exchange Resins; Antiviral Agents; Calibration; Chromatography, Liquid; Deoxycytidine; Diphosphates; Emtricitabine; Humans; Lamivudine; Leukocytes, Mononuclear; Nucleosides; Organophosphonates; Phosphates; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir; Zidovudine | 2011 |
A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study.
Topics: Adenine; Chromatography, High Pressure Liquid; Drug Stability; Humans; Lamivudine; Linear Models; Male; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir | 2012 |
Stress studies of tenofovir disoproxil fumarate by HPTLC in bulk drug and pharmaceutical formulation.
Topics: Adenine; Chloroform; Chromatography, High Pressure Liquid; Drug Stability; Hydrolysis; Methanol; Organophosphonates; Oxidation-Reduction; Pharmaceutical Preparations; Photolysis; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tenofovir; Ultraviolet Rays | 2012 |
Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde.
Topics: Acetaldehyde; Adenine; Chromatography, Liquid; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrometry, Fluorescence; Tenofovir | 2003 |
Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography.
Topics: Adenine; Chromatography, High Pressure Liquid; Drug Monitoring; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tenofovir | 2003 |
The experts speak. Studying the potential of tenofovir to prevent sexual transmission of HIV: first steps. Interview by Vicki Glaser.
Topics: Adenine; Communicable Disease Control; Female; HIV Infections; Humans; Male; Organophosphonates; Primary Prevention; Risk Assessment; Sensitivity and Specificity; Sexually Transmitted Diseases; Tenofovir; Treatment Outcome | 2005 |
Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction.
Topics: Adenine; Chromatography, High Pressure Liquid; Deoxycytidine; Drug Stability; Emtricitabine; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tenofovir | 2005 |
Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS.
Topics: Adenine; Calibration; Chromatography, High Pressure Liquid; HIV Infections; Humans; Mass Spectrometry; Organophosphonates; Reference Standards; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tenofovir | 2006 |
Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells.
Topics: Adenine; Chromatography, Liquid; Drug Stability; Humans; Leukocytes, Mononuclear; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir | 2006 |
A rapid and sensitive real-time PCR assay for the K65R drug resistance mutation in SIV reverse transcriptase.
Topics: Adenine; Animals; Disease Models, Animal; Drug Resistance, Viral; Macaca; Microbial Sensitivity Tests; Organophosphonates; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Simian Immunodeficiency Virus; Tenofovir | 2006 |
Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring.
Topics: Adenine; Calibration; Drug Monitoring; HIV Infections; Humans; Mass Spectrometry; Organophosphonates; Reference Standards; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tenofovir | 2007 |
Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma.
Topics: Adenine; Calibration; Chromatography, Liquid; Drug Stability; Freezing; Humans; Molecular Structure; Organophosphonates; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Temperature; Tenofovir; Time Factors; Zalcitabine | 2007 |